Diabetes Market Sees Advances In CGMs, Artificial Pancreas Systems, And Connectivity

The focus of the diabetes market is firmly on the development of an artificial pancreas, now within two or three years from becoming commercialized, and progress is going so well that several companies are in line to release a product. Meanwhile, digital health is increasingly playing a major role in diabetes care, and device manufacturers are investing in connectivity solutions to satisfy patient and consumer needs.

As has been the case for a number of years, the diabetes market remains quite active with ongoing research and the development of products designed to help the large patient population afflicted with the condition. However, the focus of that activity has shifted a bit as device manufacturers work to refine connectivity issues of their products, an issue that has become important in this burgeoning age of digital health. Additionally, efforts to get a fully automated artificial pancreas (AP) to market continue to make important steps forward, and it is possible the first such product could be available within two or three years. (SeeAlso see "ADA 2014: Diabetes Players Move Closer To An Artificial Pancreas" - Medtech Insight, 14 August, 2014.andAlso see "The Digital Health Care Revolution Picks Up Speed" - Medtech Insight, 14 July, 2015..)

When looking at connectivity and AP development, the industry’s eyes usually turn to two important players, Medtronic PLCand DexCom Inc., companies that have taken different routes to their current leadership positions. Medtronic is a large corporation with worldwide earnings of $20.3 billion for the company’s recently closed 2015 fiscal year, and $1.76 billion in its diabetes division for the same period. Additionally, the company has been associated with diabetes care since it rolled out its first external insulin pump, the MiniMed 502, in 1983

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight